Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Borson, S.
	Articles by VanTuinen, C.
	Search for Related Content



	PubMed Citation
	Articles by Borson, S.
	Articles by VanTuinen, C.

Psychosomatics 1992; 33:190-201
Copyright © 1992 by Academy of Psychosomatic Medicine

ORIGINAL RESEARCH REPORTS

Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease

S Borson, GJ McDonald, T Gayle, M Deffebach, S Lakshminarayan and C VanTuinen
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle 98195.

Although recent epidemiologic studies have established that patients with chronic medical illness and depressed mood are more disabled than euthymic patients, detailed data on the benefits and risks of antidepressant treatment in medically high-risk patients have been slow to accumulate. The authors have examined multiple outcome indicators in patients with disabling chronic obstructive pulmonary disease and comorbid depression. Thirty patients completed a 12-week, randomized controlled trial of nortriptyline. Nortriptyline was clearly superior to placebo for treatment of depression. Nortriptyline treatment was accompanied by marked improvements in anxiety, certain respiratory symptoms, overall physical comfort, and day-to-day function; placebo effects were negligible. Physiological measures reflecting pulmonary insufficiency were generally unaffected by treatment. These data provide impetus for renewed efforts to improve recognition and treatment of mood disorders in even severely disabled medical patients.

This article has been cited by other articles:

E. Kozer, Z. Levichek, N. Hoshino, B. Kapur, J. Leombruno, N. Taguchi, F. Garcia-Bournissen, G. Koren, and S. Ito
The Effect of Amitriptyline, Gabapentin, and Carbamazepine on Morphine-Induced Hypercarbia in Rabbits
Anesth. Analg., October 1, 2008; 107(4): 1216 - 1222.
[Abstract] [Full Text] [PDF]

J. R. Curtis
Palliative and end-of-life care for patients with severe COPD
Eur. Respir. J., September 1, 2008; 32(3): 796 - 803.
[Abstract] [Full Text] [PDF]

A. M. Kuzma, Y. Meli, C. Meldrum, P. Jellen, M. Butler-Lebair, D. Koczen-Doyle, P. Rising, K. Stavrolakes, and F. Brogan
Multidisciplinary Care of the Patient with Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2008; 5(4): 567 - 571.
[Abstract] [Full Text] [PDF]

P. N. Lanken, P. B. Terry, H. M. DeLisser, B. F. Fahy, J. Hansen-Flaschen, J. E. Heffner, M. Levy, R. A. Mularski, M. L. Osborne, T. J. Prendergast, et al.
An Official American Thoracic Society Clinical Policy Statement: Palliative Care for Patients with Respiratory Diseases and Critical Illnesses
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 912 - 927.
[Full Text] [PDF]

K. Hill, R. Geist, R. S. Goldstein, and Y. Lacasse
Anxiety and depression in end-stage COPD
Eur. Respir. J., March 1, 2008; 31(3): 667 - 677.
[Abstract] [Full Text] [PDF]

T.-P. Ng, M. Niti, W.-C. Tan, Z. Cao, K.-C. Ong, and P. Eng
Depressive Symptoms and Chronic Obstructive Pulmonary Disease: Effect on Mortality, Hospital Readmission, Symptom Burden, Functional Status, and Quality of Life
Arch Intern Med, January 8, 2007; 167(1): 60 - 67.
[Abstract] [Full Text] [PDF]

H. G. Koenig
Predictors of depression outcomes in medical inpatients with chronic pulmonary disease.
Am J Geriatr Psychiatry, November 1, 2006; 14(11): 939 - 948.
[Abstract] [Full Text] [PDF]

J. A. Cully, D. P. Graham, M. A. Stanley, C. J. Ferguson, A. Sharafkhaneh, J. Souchek, and M. E. Kunik
Quality of Life in Patients With Chronic Obstructive Pulmonary Disease and Comorbid Anxiety or Depression
Psychosomatics, August 1, 2006; 47(4): 312 - 319.
[Abstract] [Full Text] [PDF]

G. S. Alexopoulos, J. A. Sirey, P. J. Raue, D. Kanellopoulos, T. E. Clark, and R. S. Novitch
Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation.
Am J Geriatr Psychiatry, May 1, 2006; 14(5): 466 - 475.
[Abstract] [Full Text] [PDF]

H. G. Koenig
Differences Between Depressed Patients With Heart Failure and Those With Pulmonary Disease
Am J Geriatr Psychiatry, March 1, 2006; 14(3): 211 - 219.
[Abstract] [Full Text] [PDF]

H. Q. Nguyen and V. Carrieri-Kohlman
Dyspnea Self-Management in Patients With Chronic Obstructive Pulmonary Disease: Moderating Effects of Depressed Mood
Psychosomatics, October 1, 2005; 46(5): 402 - 410.
[Abstract] [Full Text] [PDF]

M. E. Kunik, K. Roundy, C. Veazey, J. Souchek, P. Richardson, N. P. Wray, and M. A. Stanley
Surprisingly High Prevalence of Anxiety and Depression in Chronic Breathing Disorders
Chest, April 1, 2005; 127(4): 1205 - 1211.
[Abstract] [Full Text] [PDF]

G. A. Brenes
Anxiety and Chronic Obstructive Pulmonary Disease: Prevalence, Impact, and Treatment
Psychosom Med, November 1, 2003; 65(6): 963 - 970.
[Abstract] [Full Text] [PDF]

J.R. Curtis and D.L. Patrick
The assessment of health status among patients with COPD
Eur. Respir. J., June 1, 2003; 21(41_suppl): 36S - 45s.
[Abstract] [Full Text] [PDF]

H. J. Schunemann, G. H. Guyatt, L. Griffith, D. Stubbing, and R. Goldstein
A Randomized Controlled Trial To Evaluate the Effect of Informing Patients About Their Pretreatment Responses to Two Respiratory Questionnaires
Chest, November 1, 2002; 122(5): 1701 - 1708.
[Abstract] [Full Text] [PDF]

G. C. Smith, D. M. Clarke, D. Handrinos, and D. P. McKenzie
Consultation-Liaison Psychiatrists' Use of Antidepressants in the Physically Ill
Psychosomatics, June 1, 2002; 43(3): 221 - 227.
[Abstract] [Full Text] [PDF]

M. A. Posternak, M. Zimmerman, G. I. Keitner, and I. W. Miller
A Reevaluation of the Exclusion Criteria Used in Antidepressant Efficacy Trials
Am J Psychiatry, February 1, 2002; 159(2): 191 - 200.
[Abstract] [Full Text] [PDF]

A. Arseven, J. M Guralnik, E. O'Brien, K. Liu, and M. M. McDermott
Peripheral arterial disease and depressed mood in older men and women
Vascular Medicine, November 1, 2001; 6(4): 229 - 234.
[Abstract] [PDF]

E J WAGENA, M J H HUIBERS, and C P VAN SCHAYCK
Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression
Thorax, August 1, 2001; 56(8): 587a - 588.
[Full Text]

M. L. Bruce
Depression and Disability in Late Life: Directions for Future Research
Am J Geriatr Psychiatry, May 1, 2001; 9(2): 102 - 112.
[Abstract] [Full Text]

E. J. Lenze, J. C. Rogers, L. M. Martire, B. H. Mulsant, B. L. Rollman, M. A. Dew, R. Schulz, and C. F. Reynolds III
The Association of Late-Life Depression and Anxiety With Physical Disability: A Review of the Literature and Prospectus for Future Research
Am J Geriatr Psychiatry, May 1, 2001; 9(2): 113 - 135.
[Abstract] [Full Text]

J. Randall Curtis and S. Borson
Examining the Link between Sarcoidosis and Depression
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 306 - 308.
[Full Text]

H. F. S. Kim, M. E. Kunik, V. A. Molinari, S. L. Hillman, S. Lalani, C. A. Orengo, N. J. Petersen, Z. Nahas, and S. Goodnight-White
Functional Impairment in COPD Patients: The Impact of Anxiety and Depression
Psychosomatics, December 1, 2000; 41(6): 465 - 471.
[Abstract] [Full Text]

P. S. Ciechanowski, W. J. Katon, and J. E. Russo
Depression and Diabetes: Impact of Depressive Symptoms on Adherence, Function, and Costs
Arch Intern Med, November 27, 2000; 160(21): 3278 - 3285.
[Abstract] [Full Text] [PDF]

I. R. Katz and J. C. Coyne
The Public Health Model for Mental Health Care for the Elderly
JAMA, June 7, 2000; 283(21): 2844 - 2845.
[Full Text] [PDF]

J. E. Streim, D. W. Oslin, I. R. Katz, B. D. Smith, S. DiFilippo, T. B. Cooper, and T. Ten Have
Drug Treatment of Depression in Frail Elderly Nursing Home Residents
Am J Geriatr Psychiatry, May 1, 2000; 8(2): 150 - 159.
[Abstract] [Full Text]

J. R. Fann, J. M. Uomoto, and W. J. Katon
Sertraline in the Treatment of Major Depression Following Mild Traumatic Brain Injury
J Neuropsychiatry Clin Neurosci, May 1, 2000; 12(2): 226 - 232.
[Abstract] [Full Text] [PDF]

G. S. Alexopoulos, M. L. Bruce, J. Hull, J. A. Sirey, and T. Kakuma
Clinical Determinants of Suicidal Ideation and Behavior in Geriatric Depression
Arch Gen Psychiatry, November 1, 1999; 56(11): 1048 - 1053.
[Abstract] [Full Text] [PDF]

E. J. Klausner and G. S. Alexopoulos
The Future of Psychosocial Treatments for Elderly Patients
Psychiatr Serv, September 1, 1999; 50(9): 1198 - 1204.
[Abstract] [Full Text] [PDF]

H. G. Koenig and M. Kuchibhatla
Use of Health Services by Medically Ill Depressed Elderly Patients After Hospital Discharge
Am J Geriatr Psychiatry, February 1, 1999; 7(1): 48 - 56.
[Abstract] [Full Text]

A. V. Prochazka, M. J. Weaver, R. T. Keller, G. E. Fryer, P. A. Licari, and D. Lofaso
A Randomized Trial of Nortriptyline for Smoking Cessation
Arch Intern Med, October 12, 1998; 158(18): 2035 - 2039.
[Abstract] [Full Text] [PDF]

H. G. Koenig and M. Kuchibhatla
Use of Health Services by Hospitalized Medically Ill Depressed Elderly Patients
Am J Psychiatry, July 1, 1998; 155(7): 871 - 877.
[Abstract] [Full Text]

J. W. Smoller, M. H. Pollack, D. Systrom, and R. L. Kradin
Sertraline Effects on Dyspnea in Patients With Obstructive Airways Disease
Psychosomatics, February 1, 1998; 39(1): 24 - 29.
[Abstract] [Full Text]

J.�R. CURTIS, D.�P. MARTIN, and T.�R. MARTIN
Patient-assessed Health Outcomes in Chronic Lung Disease . What are They, How Do They Help Us, and Where Do We Go From Here?
Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1032 - 1039.
[Full Text] [PDF]

Get information about faster international access.